CD133-positive cells for cardiac stem cell therapy: Current status and outlook

Advances in Experimental Medicine and Biology

Volumn 777, Issue , 2013, Pages 215-227

  Donndorf, Peter ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

CABG; CD133; Coronary intervention; Intramyocardial; Surgery stem cell

Indexed keywords

CD133 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CORONARY ARTERY BYPASS GRAFT; GENE DELIVERY SYSTEM; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART SURGERY; HEMATOPOIETIC STEM CELL; HUMAN; INTRACORONARY INFUSION; ISCHEMIC HEART DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; BIOLOGICAL THERAPY; HEART; HEART FAILURE; HEART MUSCLE ISCHEMIA;

CELL- AND TISSUE-BASED THERAPY; HEART; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION;

EID: 84934438851     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5894-4_14     Document Type: Article

References (48)

1. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98:10344-10349
2. Uemura R, Xu M, Ahmad N, Ashraf M (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421
3. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98-102
4. Donndorf P, Strauer BE, Steinhoff G (2012) Update on cardiac stem cell therapy in heart failure. Curr Opin Cardiol 27:154-160
5. Strauer BE, Yousef M, Schannwell CM (2012) The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 12:721-729
6. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B et al (2007) Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and ef fi cacy studies. J Thorac Cardiovasc Surg 133:717-725
7. Allgöwer M (1956) The cellular basis of wound repair. Charles C. Thomas. Oxford Blackwell, Spring fi eld, III
8. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R et al (2001) Multiorgan, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-377
9. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49
10. Quaini F, Urbanek K, Graiani G, Lagrasta C, Maestri R, Monica M et al (2004) The regenerative potential of the human heart. Int J Cardiol 95:S26-S28
11. Goodell MA, Jackson KA, Majka SM, Mi T, Wang H, Pocius J et al (2001) Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 938:208-218, discussion 18-20
12. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G et al (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530
13. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705
14. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668
15. Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451:937-942
16. Hock H (2010) Some hematopoietic stem cells are more equal than others. J Exp Med 207:1127-1130
17. Tse HF, Yiu KH, Lau CP (2007) Bone marrow stem cell therapy for myocardial angiogenesis. Curr Vasc Pharmacol 5:103-112
18. Ma N, Ladilov Y, Kaminski A, Piechaczek C, Choi YH, Li W et al (2006) Umbilical cord blood cell transplantation for myocardial regeneration. Transplant Proc 38:771-773
19. Ma N, Ladilov Y, Moebius JM, Ong L, Piechaczek C, David A et al (2006) Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovasc Res 71:158-169
20. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med 7:430-436
21. Ong LL, Li W, Oldigs JK, Kaminski A, Gerstmayer B, Piechaczek C et al (2007) Hypoxic/ normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells. Tissue Eng Part C Methods 16:1069-1081
22. Gao LR, Xu RY, Zhang NK, Chen Y, Wang ZG, Zhu ZM et al (2008) Increased apelin following bone marrow mononuclear cell transplantation contributes to the improvement of cardiac function in patients with severe heart failure. Cell Transplant 18:1311-1318
23. Bonaros N, Rauf R, Werner E, Schlechta B, Rohde E, Kocher A et al (2008) Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Interact Cardiovasc Thorac Surg 7:249-255
24. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H et al (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46
25. Chachques JC (2009) Cellular cardiac regenerative therapy in which patients? Expert Rev Cardiovasc Ther 7:911-919
26. Kaminski A, Steinhoff G (2008) Current status of intramyocardial bone marrow stem cell transplantation. Semin Thorac Cardiovasc Surg 20:119-125
27. Soeki T, Tamura Y, Shinohara H, Tanaka H, Bando K, Fukuda N (2000) Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology 93:168-174
28. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L et al (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114-1122
29. Menasche P (2011) Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 50:258-265
30. Larose E, Proulx G, Voisine P, Rodes-Cabau J, De Larochelliere R, Rossignol G et al (2010) Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Catheter Cardiovasc Interv 75:120-127
31. Hu S, Liu S, Zheng Z, Yuan X, Li L, Lu M et al (2011) Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 57:2409-2415
32. Zhao Q, Sun Y, Xia L, Chen A, Wang Z (2008) Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 86:1833-1840
33. Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, Bijnens E et al (2006) Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114:I101-I107
34. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R et al (2005) Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 130:1631-1638
35. Mocini D, Staibano M, Mele L, Giannantoni P, Menichella G, Colivicchi F et al (2006) Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. Am Heart J 151:192-197
36. Ahmadi H, Baharvand H, Ashtiani SK, Soleimani M, Sadeghian H, Ardekani JM et al (2007) Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction. Curr Neurovasc Res 4:153-160
37. Klein HM, Ghodsizad A, Marktanner R, Poll L, Voelkel T, Mohammad Hasani MR et al (2007) Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 10:E66-E69
38. Donndorf P, Kundt G, Kaminski A, Yerebakan C, Liebold A, Steinhoff G et al (2011) Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J Thorac Cardiovasc Surg 142:911-920
39. Yerebakan C, Kaminski A, Westphal B, Donndorf P, Glass A, Liebold A et al (2011) Impact of preoperative left ventricular function and time from infarction on the long-term bene fi ts after intramyocardial CD133(+) bone marrow stem cell transplant. J Thorac Cardiovasc Surg 142:1530-9.e3
40. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B et al (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111:2198-2202
41. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989-997
42. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J et al (2007) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50:1761-1767
43. Mansour S, Roy DC, Bouchard V, Nguyen BK, Stevens LM, Gobeil F et al (2010) COMPAREAMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design. J Cardiovasc Transl Res 3:153-159
44. Nasseri BA, Kukucka M, Dandel M, Knosalla C, Choi YH, Ebell W et al (2009) Twodimensional speckle tracking strain analysis for ef fi cacy assessment of myocardial cell therapy. Cell transplant 18:361-370
45. Pompillio G, Steinhoff G, Liebold A, Pesce M, Alemanni F, Capogrossi MC et al (2008) Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 56:71-76
46. Bartunek J, Vanderheyden M, Vanderkerckhove B, Mansour S, De Bryne B, de Bondt P et al (2005) Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112:I178-I183
47. Manginas A, Goussetis E, Koutelou M, Karatasakis G, Peristeri I, Theodorakos A et al (2007) Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction. Catheter Cardiovasc Interv 69:773-781
48. Colombo A, Castellani M, Piccaluga E, Pusineri E, Palatresi S, Longari V et al (2011) Myocardial blood fl ow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial. J Cardiovasc Med 12:239-248